Clinical Challenges in Israel: Solutions for Improvement and Innovation

18

February

  • 4PM Tel Aviv / 2PM London / 10 AM New York
  • Free
  • Why attend?
  • Speakers
  • Contact Us

Why attend?

The complexity of clinical trial data management has surged over the past decade.

This webinar will review some of the clinical challenges in Israel, identifying clinical trends observed by different Biotech’s, and share solutions to help overcome these challenges. We will be joined by industry experts from Israel, who will join a panel during the webinar to discuss…

  • How using disparate systems / siloed solutions affects data quality.
  • Solving the challenges of bringing together different data sources.

 

Speakers:

Ari Feldman – SVP, Global Compliance & Strategy at Medidata

Guest Panelist: TBC

Finn Harkin – Solutions Consultant at Medidata

 Learning opportunities:

 

  • Find out about innovative approaches to clinical challenges in Israel
  • Solving the challenges of bringing together different data sources
  • How to eliminate complex, manual processes and deliver higher quality data for faster insights

Speakers

Select a speaker to learn more

Back
Ari Feldman- SVP
Global Compliance & Strategy at Medidata

As the leader of Medidata’s Global Compliance & Strategy function,  Ari applies a risk based approach to navigating and interpreting the global regulatory landscape of the clinical trial ecosystem.  With nearly 25 years of experience working with regulated industries, Ari integrates cross functionally to bring a balanced application of compliance, governance, risk, and controls within Medidata’s products and services.  Leveraging the experience of an international team, Ari actively promotes increased trust and transparency regarding the areas that matter most in maximizing the potential of the Medidata Platform.

Next speaker
Back
Dr. Ofra Levy-Hacham
VP Clinical and Regulatory Affairs at Sol-Gel

Dr. Ofra Levy-Hacham has served as our vice president of clinical and regulatory affairs since March 2018, and before that since joining us in 2011, she served as our vice president of quality and regulatory affairs. Prior to joining Sol-Gel, Dr. Levy-Hacham served as a scientific specialist and project manager at Biotechnology General Ltd., a fully integrated biopharmaceutical services private company from 2010 until 2011. From 2008 until 2010, Dr. Levy-Hacham served as vice president chemistry, manufacturing and controls at HealOr Ltd., a private company engaging in the development of therapeutics for the treatment of various skin lesions and conditions. Dr. Levy-Hacham holds a Ph.D. in chemistry from The Technion - Israel Institute of Technology, Israel.

Next speaker
Back
Sharon Gai
Head of Clinical Department at Kamada

Sharon Gai-Castro currently serves at Head of Clinical at Kamada, a commercial-stage global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions, and are a leader in the specialty plasma-derived field focused on diseases with limited treatment alternatives.

Prior to joining Kamada, Sharon held positions as Clinical Research Manager at Merck & Co. and Clinical Research Associate at Parexel.

Sharon holds a Master’s Degree in Neuroscience from Tel-Aviv University.

Next speaker

Enquiry